S&P 500   3,254.24 (+0.54%)
DOW   26,869.45 (+0.40%)
QQQ   267.10 (+1.11%)
AAPL   108.81 (+1.58%)
MSFT   204.11 (+1.75%)
FB   249.39 (+0.15%)
GOOGL   1,418.54 (+0.65%)
AMZN   3,036.00 (+1.20%)
NVDA   496.50 (+2.38%)
TSLA   388.30 (+2.09%)
BABA   269.24 (-1.36%)
CGC   14.50 (-0.68%)
GE   6.10 (-0.16%)
MU   49.63 (-0.44%)
AMD   75.98 (+1.67%)
T   28.02 (+0.54%)
F   6.61 (-0.45%)
ACB   5.23 (+1.16%)
GILD   62.40 (-1.09%)
NFLX   471.56 (+0.20%)
DIS   122.41 (-0.71%)
BAC   23.53 (+1.16%)
BA   146.10 (-3.36%)
S&P 500   3,254.24 (+0.54%)
DOW   26,869.45 (+0.40%)
QQQ   267.10 (+1.11%)
AAPL   108.81 (+1.58%)
MSFT   204.11 (+1.75%)
FB   249.39 (+0.15%)
GOOGL   1,418.54 (+0.65%)
AMZN   3,036.00 (+1.20%)
NVDA   496.50 (+2.38%)
TSLA   388.30 (+2.09%)
BABA   269.24 (-1.36%)
CGC   14.50 (-0.68%)
GE   6.10 (-0.16%)
MU   49.63 (-0.44%)
AMD   75.98 (+1.67%)
T   28.02 (+0.54%)
F   6.61 (-0.45%)
ACB   5.23 (+1.16%)
GILD   62.40 (-1.09%)
NFLX   471.56 (+0.20%)
DIS   122.41 (-0.71%)
BAC   23.53 (+1.16%)
BA   146.10 (-3.36%)
S&P 500   3,254.24 (+0.54%)
DOW   26,869.45 (+0.40%)
QQQ   267.10 (+1.11%)
AAPL   108.81 (+1.58%)
MSFT   204.11 (+1.75%)
FB   249.39 (+0.15%)
GOOGL   1,418.54 (+0.65%)
AMZN   3,036.00 (+1.20%)
NVDA   496.50 (+2.38%)
TSLA   388.30 (+2.09%)
BABA   269.24 (-1.36%)
CGC   14.50 (-0.68%)
GE   6.10 (-0.16%)
MU   49.63 (-0.44%)
AMD   75.98 (+1.67%)
T   28.02 (+0.54%)
F   6.61 (-0.45%)
ACB   5.23 (+1.16%)
GILD   62.40 (-1.09%)
NFLX   471.56 (+0.20%)
DIS   122.41 (-0.71%)
BAC   23.53 (+1.16%)
BA   146.10 (-3.36%)
S&P 500   3,254.24 (+0.54%)
DOW   26,869.45 (+0.40%)
QQQ   267.10 (+1.11%)
AAPL   108.81 (+1.58%)
MSFT   204.11 (+1.75%)
FB   249.39 (+0.15%)
GOOGL   1,418.54 (+0.65%)
AMZN   3,036.00 (+1.20%)
NVDA   496.50 (+2.38%)
TSLA   388.30 (+2.09%)
BABA   269.24 (-1.36%)
CGC   14.50 (-0.68%)
GE   6.10 (-0.16%)
MU   49.63 (-0.44%)
AMD   75.98 (+1.67%)
T   28.02 (+0.54%)
F   6.61 (-0.45%)
ACB   5.23 (+1.16%)
GILD   62.40 (-1.09%)
NFLX   471.56 (+0.20%)
DIS   122.41 (-0.71%)
BAC   23.53 (+1.16%)
BA   146.10 (-3.36%)
Log in
NASDAQ:NVUS

Novus Therapeutics Short Interest Ratio and Short Volume

$0.92
-0.05 (-5.07 %)
(As of 09/24/2020 12:26 PM ET)
Add
Compare
Today's Range
$0.88
Now: $0.92
$0.97
50-Day Range
$0.38
MA: $0.51
$1.11
52-Week Range
$0.25
Now: $0.92
$1.45
Volume23,206 shs
Average Volume1.74 million shs
Market Capitalization$17.83 million
P/E RatioN/A
Dividend YieldN/A
Beta3.12

Short Interest

Novus Therapeutics (NASDAQ:NVUS) Short Interest Data

Current Short Volume:211,400 shares
Previous Short Volume:198,500 shares
Change Vs. Previous Month:+6.50%
Dollar Volume Sold Short:$82,446.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:August, 31 2020
Outstanding Shares:12,980,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:23,206 shares
Average Trading Volume:1,738,711 shares
Today's Volume Vs. Average:-98.67%



Novus Therapeutics (NASDAQ:NVUS) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
8/31/2020211,400 $82,446.00 6.5%0.0%0.4$0.39
8/14/2020198,500 $81,385.00 11.5%0.0%0.2$0.41
7/31/2020178,100 $74,802.00 -11.4%0.0%0.1$0.42
7/15/2020201,000 $92,460.00 -35.1%0.0%0.2$0.46
6/30/2020309,900 $154,950.00 52.9%0.0%0.3$0.50
6/15/2020202,700 $91,215.00 421.1%0.0%0.2$0.45
5/29/202038,900 $20,228.00 -70.6%0.0%0$0.52
5/15/2020132,100 $167,767.00 118.0%0.0%0.3$1.27
4/30/202060,600 $69,084.00 265.1%0.0%0.3$1.14
4/15/202016,600 $10,624.00 -76.7%0.0%0.1$0.64
3/31/202071,200 $44,144.00 21.3%0.0%0.3$0.62
3/13/202058,700 $21,719.00 -20.8%0.0%0.4$0.37
2/28/202074,100 $22,971.00 1,057.8%0.0%0.3$0.31
2/14/20206,400 $3,008.00 -69.8%0.0%0$0.47
1/31/202021,200 $11,448.00 8.7%0.2%0.1$0.54
1/15/202019,500 $10,335.00 -67.5%0.2%0.2$0.53
12/31/201960,000 $38,400.00 482.5%0.5%0.4$0.64

Novus Therapeutics (NASDAQ:NVUS) Short Interest FAQ

speech bubbles
speech bubbles











What is Novus Therapeutics' current short interest?

Short interest is the volume of Novus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 211,400 shares of NVUS short. 0.00% of Novus Therapeutics' shares are currently sold short. View details.

Is Novus Therapeutics' short interest increasing or decreasing?

Novus Therapeutics saw a increase in short interest in August. As of August 31st, there was short interest totaling 211,400 shares, an increase of 6.5% from the previous total of 198,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Novus Therapeutics' short interest compare to its competitors?

0.00% of Novus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Novus Therapeutics: Assertio Therapeutics, Inc. (0.00%), DiaMedica Therapeutics Inc (0.00%), Novan Inc (0.00%), Trevi Therapeutics Inc (0.95%), Clearside Biomedical Inc (4.73%), Edesa Biotech (3.22%), Oncolytics Biotech, Inc. (5.31%), Mereo BioPharma Group plc (0.00%), RegeneRx Biopharmaceuticals Inc (0.00%), and Elite Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.13 billion), Aon PLC ($3.40 billion), Clorox Co ($3.09 billion), ViacomCBS Inc. ($2.81 billion), Charles Schwab Co. ($2.80 billion), Kroger Co ($1.95 billion), Simon Property Group Inc ($1.82 billion), Restoration Hardware Holdings, Inc ($1.71 billion), International Flavors & Fragrances Inc ($1.69 billion), and C.H. Robinson Worldwide Inc ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Novus Therapeutics stock?

Short selling NVUS is an investing strategy that aims to generate trading profit from Novus Therapeutics as its price is falling. Novus Therapeutics' stock is trading down $0.05 today. To short Novus Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Novus Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Novus Therapeutics?

A short squeeze for Novus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NVUS, which in turn drives the price of the stock up even further.

How often is Novus Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVUS, twice per month. The most recent reporting period available is August, 31 2020.


This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.